Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OBINUTUZUMAB vs ODEVIXIBAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OBINUTUZUMAB vs ODEVIXIBAT: Safety Overview

Metric OBINUTUZUMAB ODEVIXIBAT
Total FAERS Reports 14,189 223
Deaths Reported 1,919 10
Death Rate 13.5% 4.5%
Hospitalizations 5,419 43
Average Patient Age 63.8 yrs 14.3 yrs
% Female Patients 41.7% 49.4%
FDA Approval Date N/A Jul 20, 2021
Manufacturer Genentech, Inc. Albireo Pharma, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription